ARDELYX, INC. Increase (Decrease) in Receivables
ARDELYX, INC. (ARDX) reported Increase (Decrease) in Receivables of -$2.39 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2019-11-06
- ARDELYX, INC. increase (decrease) in receivables for the quarter ending 2019-09-30 was $2.68M, a 1857.66% increase year-over-year.
- ARDELYX, INC. increase (decrease) in receivables for the quarter ending 2019-06-30 was $10.00K, a 66.67% decline year-over-year.
- ARDELYX, INC. increase (decrease) in receivables for the quarter ending 2019-03-31 was -$5.08M.
- ARDELYX, INC. increase (decrease) in receivables for the quarter ending 2018-09-30 was $137.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month |
|---|---|---|---|
| 2019-09-30 | $2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.69M derived: sum of 2 quarters · filed 2019-11-06 | -$2.39M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$5.07M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$5.08M 10-Q · filed 2019-05-07 | ||
| 2018-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $167.00K derived: sum of 2 quarters · filed 2019-11-06 | -$10.63M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$10.77M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | -$10.80M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |